128 related articles for article (PubMed ID: 25383957)
1. Deficiency of interferon-gamma or its receptor promotes colorectal cancer development.
Wang L; Wang Y; Song Z; Chu J; Qu X
J Interferon Cytokine Res; 2015 Apr; 35(4):273-80. PubMed ID: 25383957
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous deletion of ATG5 in Apc(Min/+) mice promotes intestinal adenoma growth and enhances the antitumor efficacy of interferon-gamma.
Wang L; Wang Y; Lu Y; Zhang Q; Qu X
Cancer Biol Ther; 2015; 16(3):383-91. PubMed ID: 25695667
[TBL] [Abstract][Full Text] [Related]
3. Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.
Zhang Y; Xiao Q; Zhang H; Sun X; Ge H; Liu X; Guan L; Sun M
Oncol Rep; 2014 Apr; 31(4):1811-7. PubMed ID: 24573033
[TBL] [Abstract][Full Text] [Related]
4. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
5. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma.
Jouanguy E; Dupuis S; Pallier A; Döffinger R; Fondanèche MC; Fieschi C; Lamhamedi-Cherradi S; Altare F; Emile JF; Lutz P; Bordigoni P; Cokugras H; Akcakaya N; Landman-Parker J; Donnadieu J; Camcioglu Y; Casanova JL
J Clin Invest; 2000 May; 105(10):1429-36. PubMed ID: 10811850
[TBL] [Abstract][Full Text] [Related]
6. Identification and regulation of testicular interferon-gamma (IFNgamma) receptor subunits: IFNgamma enhances interferon regulatory factor-1 and interleukin-1beta converting enzyme expression.
Kanzaki M; Morris PL
Endocrinology; 1998 May; 139(5):2636-44. PubMed ID: 9564881
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-γ in esophageal cancer cells.
Akagami M; Kawada K; Kubo H; Kawada M; Takahashi M; Kaganoi J; Kato S; Itami A; Shimada Y; Watanabe G; Sakai Y
Ann Surg Oncol; 2011 Dec; 18(13):3868-77. PubMed ID: 21452064
[TBL] [Abstract][Full Text] [Related]
8. Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway.
Ding H; Wang G; Yu Z; Sun H; Wang L
Biomed Pharmacother; 2022 Nov; 155():113683. PubMed ID: 36095965
[TBL] [Abstract][Full Text] [Related]
9. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
10. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
11. PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers.
Wang X; Li X; Fan F; Jiao S; Wang L; Zhu L; Pan Y; Wu G; Ling ZQ; Fang J; Chen Y
Carcinogenesis; 2012 Nov; 33(11):2228-35. PubMed ID: 22828136
[TBL] [Abstract][Full Text] [Related]
12. Expression of IFNγR2 mutated in a dileucine internalization motif reinstates IFNγ signaling and apoptosis in human T lymphocytes.
Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F
Immunol Lett; 2010 Nov; 134(1):17-25. PubMed ID: 20709103
[TBL] [Abstract][Full Text] [Related]
13. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
14. Influence of interferon-alpha and ribavirin on the transcription of interferon-gamma and IFN-gamma receptor genes in Jurkat cells.
Sypniewski D; Bednarek I; Gałka S; Loch T; Machnik G
Acta Pol Pharm; 2008; 65(3):345-51. PubMed ID: 18646554
[TBL] [Abstract][Full Text] [Related]
15. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
16. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
[TBL] [Abstract][Full Text] [Related]
17. IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology.
Stange J; Hepworth MR; Rausch S; Zajic L; Kühl AA; Uyttenhove C; Renauld JC; Hartmann S; Lucius R
J Immunol; 2012 Mar; 188(5):2410-8. PubMed ID: 22266282
[TBL] [Abstract][Full Text] [Related]
18. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
Couturier D
Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer.
Lin PL; Wu DW; Huang CC; He TY; Chou MC; Sheu GT; Lee H
Carcinogenesis; 2014 Oct; 35(10):2175-82. PubMed ID: 24832083
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile.
Coyle AJ; Tsuyuki S; Bertrand C; Huang S; Aguet M; Alkan SS; Anderson GP
J Immunol; 1996 Apr; 156(8):2680-5. PubMed ID: 8609383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
